|
|
| |
| |
A
World-Class Manufacturing Service
Encap offers it customers a highly
personalised manufacturing service from early
stage R&D utilising liquid and semi solid
capsule development through to commercial scale
cGMP capsule manufacture. Throughout the clinical
trial process, product launch and marketing, Encap
can support the supply demands for a wide range
of drug products and has proven capability in
addressing those with poor solubility or high
potency and cytotoxic/cytostatic compounds that
require specialist containment.
Our product expertise extends to cover a wide
range of therapeutics and nutritional supplements
including oncolytics, cardiovascular, analgesics,
controlled-release formulations, hygroscopic and
oxidation-sensitive compounds, bioavailability
enhancement, nutritional supplements such as anti-oxidants,
anti-oestrogens, anti-inflammatories, anti-psychotics,
hormones, immunosuppressant's, laxatives and steroids.
Our current production capacity is in excess of
300 million capsules per annum which continues to expand
to meet our growing customer demand. Encap operates
to cGMP, holds an MHRA Licence for Investigational
Medicinal Products (IMP’s) and is able to
meet the stringent quality requirements set by
the world’s most demanding regulatory bodies. |
|
|
